News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GUGGENHIME ANDREW
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/23/2023 |
4
| GUGGENHIME ANDREW (Director) has filed a Form 4 on Caribou Biosciences, Inc.|
Txns:
| Granted 21,500 options to buy
@ $6.12, valued at
$131.6k
|
|
| 01/04/2023 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 42,000 options to buy
@ $47.95, valued at
$2M
Exercised 23,691 options to buy
@ $5.35, valued at
$126.7k
|
|
| 09/21/2022 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 2,623 shares
@ $26.019, valued at
$68.2k
Sold 477 shares
@ $26.52, valued at
$12.7k
Exercised 3,100 options to buy
@ $5.35, valued at
$16.6k
|
|
| 09/07/2022 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Paid exercise price by delivering 4,649 shares
@ $26.38, valued at
$122.6k
|
|
| 09/06/2022 |
4
| GUGGENHIME ANDREW (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
| 08/29/2022 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 17,052 shares
@ $28, valued at
$477.5k
Sold 1,295 shares
@ $28, valued at
$36.3k
Sold 17,653 shares
@ $28, valued at
$494.3k
Exercised 17,052 options to buy
@ $5.35, valued at
$91.2k
Exercised 1,295 options to buy
@ $5.35, valued at
$6.9k
Exercised 17,653 options to buy
@ $5.35, valued at
$94.4k
|
|
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2022 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 3,091 shares
@ $24.53, valued at
$75.8k
Sold 9 shares
@ $25, valued at
$225
Exercised 3,100 options to buy
@ $5.35, valued at
$16.6k
|
|
| 07/12/2022 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 3,100 shares
@ $24, valued at
$74.4k
Exercised 3,100 options to buy
@ $5.35, valued at
$16.6k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2022 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 3,100 shares
@ $24.0459, valued at
$74.5k
Exercised 3,100 options to buy
@ $5.35, valued at
$16.6k
|
|
| 03/22/2022 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 3,100 shares
@ $26.1267, valued at
$81k
Exercised 3,100 options to buy
@ $5.35, valued at
$16.6k
|
|
| 03/04/2022 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 37,500 shares
@ $0
Granted 225,000 options to buy
@ $24.79, valued at
$5.6M
|
|
| 03/03/2022 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 6,200 shares
@ $24, valued at
$148.8k
Exercised 6,200 options to buy
@ $5.35, valued at
$33.2k
|
|
| 12/28/2021 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 3,100 shares
@ $24, valued at
$74.4k
Exercised 3,100 options to buy
@ $5.35, valued at
$16.6k
|
|
| 12/21/2021 |
4
| GUGGENHIME ANDREW (Director) has filed a Form 4 on Caribou Biosciences, Inc.|
Txns:
| Granted 27,500 options to buy
@ $15.16, valued at
$416.9k
|
|
| 11/22/2021 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 2,985 shares
@ $24.5, valued at
$73.1k
Sold 115 shares
@ $25.2, valued at
$2.9k
Exercised 3,100 options to buy
@ $5.35, valued at
$16.6k
|
|
| 07/22/2021 |
3
| GUGGENHIME ANDREW (Director) has filed a Form 3 on Caribou Biosciences, Inc. |
| 05/25/2021 |
4
| GUGGENHIME ANDREW (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $4.07, valued at
$67.2k
|
|
| 04/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2020 |
3
| GUGGENHIME ANDREW (Director) has filed a Form 3 on Metacrine, Inc. |
| 06/11/2020 |
3
| GUGGENHIME ANDREW (CFO, CBO) has filed a Form 3 on Vaxcyte, Inc. |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2019 |
4
| GUGGENHIME ANDREW (CFO) has filed a Form 4 on Dermira, Inc.|
Txns:
| Paid exercise price by delivering 986 shares
@ $7.91, valued at
$7.8k
Paid exercise price by delivering 1,233 shares
@ $7.91, valued at
$9.8k
Paid exercise price by delivering 1,232 shares
@ $7.91, valued at
$9.7k
Exercised 3,563 restricted stock units
@ $0
Exercised 2,850 restricted stock units
@ $0
Exercised 3,562 restricted stock units
@ $0 |
|
| 05/21/2019 |
4
| GUGGENHIME ANDREW (CFO) has filed a Form 4 on Dermira, Inc.|
Txns:
| Paid exercise price by delivering 8,645 shares
@ $10.5, valued at
$90.8k
Exercised 25,000 restricted stock units
@ $0 |
|
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2018 |
4
| GUGGENHIME ANDREW (COO and CFO) has filed a Form 4 on Dermira, Inc.|
Txns:
| Paid exercise price by delivering 329 shares
@ $9.58, valued at
$3.2k
Paid exercise price by delivering 1,232 shares
@ $9.58, valued at
$11.8k
Paid exercise price by delivering 1,233 shares
@ $9.58, valued at
$11.8k
Granted 50,000 restricted stock units
@ $0
Exercised 950 restricted stock units
@ $0
Exercised 3,562 restricted stock units
@ $0
Exercised 3,563 restricted stock units
@ $0 |
|
| 02/16/2018 |
4
| GUGGENHIME ANDREW (COO and CFO) has filed a Form 4 on Dermira, Inc.|
Txns:
| Granted 57,000 options to buy
@ $28.25, valued at
$1.6M
Granted 9,500 restricted stock units
@ $0 |
|
| 08/17/2017 |
4
| GUGGENHIME ANDREW (COO and CFO) has filed a Form 4 on Dermira, Inc.|
Txns:
| Paid exercise price by delivering 1,339 shares
@ $23.58, valued at
$31.6k
Paid exercise price by delivering 447 shares
@ $23.58, valued at
$10.5k
Exercised 1,188 restricted stock units
@ $0
Exercised 3,562 restricted stock units
@ $0 |
|
| 02/22/2017 |
4
| GUGGENHIME ANDREW (COO and CFO) has filed a Form 4 on Dermira, Inc. |
| 11/10/2016 |
4
| GUGGENHIME ANDREW (COO and CFO) has filed a Form 4 on Dermira, Inc. |
| 10/13/2016 |
4
| GUGGENHIME ANDREW (COO and CFO) has filed a Form 4 on Dermira, Inc. |
| 09/20/2016 |
4
| GUGGENHIME ANDREW (COO and CFO) has filed a Form 4 on Dermira, Inc. |
| 09/14/2016 |
4
| GUGGENHIME ANDREW (COO and CFO) has filed a Form 4 on Dermira, Inc. |
|
|
|